polymorphism analysis: Clinical Trials

120 trials of polymorphism analysis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed, 31 unknown, 13 terminated, 3 withdrawn. 23 Phase 2, 14 Phase 1, 2 Not applicable, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 223Completed 16, Terminated 4, Unknown 3
Phase 114Completed 9, Terminated 3, Unknown 1, Withdrawn 1
Not applicable2Completed 1, Unknown 1
Phase 32Completed 2

Follow polymorphism analysis: new trials by email Literature Review of polymorphism analysis trials Research Report on polymorphism analysis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
polymorphism analysis, Doxorubicin-Cyclophosphamide regimen - Breast Cancer Patients
UnknownDamanhour University1002020-12-012020-12-04
Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients
polymorphism analysis, Doxorubicin-Cyclophosphamide regimen - Breast Cancer Patients
UnknownDamanhour University1002020-10-152020-10-09
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
polymorphism analysis - Gastrointestinal Tract Cancer, Peripheral Neuropathy
UnknownAin Shams University802014-11-012023-11-28
Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia
DNA analysis, genetic linkage analysis, microarray analysis - Leukemia
CompletedChildren's Oncology Group3502013-02-012016-07-11
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
DNA analysis, RNA analysis, gene expression analysis - Lung Cancer, Lymphoma
TerminatedAIDS Malignancy Consortium1142013-01-022023-03-16
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
mutation analysis, polymerase chain reaction, polymorphism analysis - Head and Neck Cancer
CompletedEastern Cooperative Oncology Group1832012-06-012017-05-17
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
DNA methylation analysis, RNA analysis, allele-specific oligonucleotide real-time quantitative polymerase chain reaction - Kidney Cancer
CompletedChildren's Oncology Group402012-04-012016-05-18
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
DNA analysis, DNA methylation analysis, RNA analysis - Lung Cancer
CompletedAlliance for Clinical Trials in Oncology2482012-03-012017-06-27
Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
rituximab, DNA analysis, gene expression analysis - Lymphoma
CompletedECOG-ACRIN Cancer Research Group2592012-02-062017-05-17
Studying Genes in Samples From Younger Patients With Adrenocortical Tumor
DNA methylation analysis, RNA analysis, gene expression analysis - Adrenocortical Carcinoma
CompletedChildren's Oncology Group102012-02-012016-05-18
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
brentuximab vedotin, doxorubicin hydrochloride, vinblastine - Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma
Phase 2CompletedNorthwestern University492011-11-012026-05-22
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
DNA methylation analysis, RNA analysis, mutation analysis - Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
CompletedChildren's Oncology Group902011-10-012016-05-18
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
gene expression analysis, mutation analysis, polymorphism analysis - Leukemia, Lymphoma
UnknownEuropean Organisation for Research and Treatment of Cancer - EORTC12002011-06-012017-07-28
Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer
polymorphism analysis, immunologic technique, laboratory biomarker analysis - Pancreatic Cancer
CompletedAlliance for Clinical Trials in Oncology2652011-06-012016-06-29
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
DNA analysis, cytogenetic analysis, gene expression analysis - Brain and Central Nervous System Tumors, Hereditary Wilms Tumor
CompletedChildren's Oncology Group312011-05-012016-07-11
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
DNA analysis, gene expression analysis, polymorphism analysis - Breast Cancer
CompletedECOG-ACRIN Cancer Research Group3632011-04-052017-05-17
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
everolimus, lenalidomide, laboratory biomarker analysis - Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Phase 1 / Phase 2CompletedMayo Clinic582011-01-102020-10-22
Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia
alemtuzumab, rituximab, PGG beta-glucan - B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia
Phase 1 / Phase 2CompletedMayo Clinic222011-01-012020-06-23
Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07
polymorphism analysis, laboratory biomarker analysis, quality-of-life assessment - Breast Cancer
CompletedETOP IBCSG Partners Foundation1042011-01-012026-10-06
Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck
erlotinib hydrochloride, intensity-modulated radiation therapy, pharmacogenomic studies - Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx
Phase 2TerminatedCase Comprehensive Cancer Center22011-01-012020-05-12

Showing 20 of 120. Sign in to see all of them.

Conditions studied

Breast Neoplasms (24)  ·  Leukemia (13)  ·  Lymphoma (13)  ·  Lymphoma, Follicular (12)  ·  Colonic Neoplasms (10)  ·  Prostatic Neoplasms (10)  ·  Rectal Neoplasms (10)  ·  Carcinoma, Non-Small-Cell Lung (9)  ·  Lymphoma, Large B-Cell, Diffuse (9)  ·  Colorectal Neoplasms (8)  ·  Lung Neoplasms (8)  ·  Congenital Abnormalities (7)  ·  Hodgkin Disease (7)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (7)  ·  Lymphoma, B-Cell, Marginal Zone (7)

Sponsors

Children's Oncology Group (10)  ·  ECOG-ACRIN Cancer Research Group (9)  ·  Cancer Research UK (8)  ·  SWOG Cancer Research Network (8)  ·  Alliance for Clinical Trials in Oncology (7)  ·  Case Comprehensive Cancer Center (6)  ·  Eastern Cooperative Oncology Group (6)  ·  Mayo Clinic (4)  ·  University of Nebraska (4)  ·  Vanderbilt-Ingram Cancer Center (4)  ·  Children's Cancer and Leukaemia Group (3)  ·  Fred Hutchinson Cancer Center (3)  ·  Damanhour University (2)  ·  Gynecologic Oncology Group (2)  ·  NSABP Foundation Inc (2)

Countries

United States (50)  ·  United Kingdom (19)  ·  France (4)  ·  Egypt (3)  ·  Ireland (3)  ·  Australia (2)  ·  Belgium (2)  ·  China (2)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Portugal (1)  ·  Puerto Rico (1)

Top investigators

Paul Pharoah, MD (7)  ·  Jill Kolesar, PharmD (3)  ·  Angela Cox, PhD (2)  ·  Brad S. Kahl, MD (2)  ·  Bryan P. Schneider, MD (2)  ·  Christine B. Ambrosone, PhD (2)  ·  Elinor Sawyer, MD (2)  ·  Gareth Veal (2)  ·  Heinz-Josef Lenz, MD (2)  ·  James N. Ingle, MD (2)  ·  Madan Jagasia, MD (2)  ·  Rebecca Roylance, MD (2)  ·  Alan Venook, MD (1)  ·  Allison C. Rosenthal, D.O. (1)

Results publications

PMID 15662127, PMID 18483359, PMID 20035238, PMID 20309628, PMID 21169260, PMID 21880792, PMID 22271896, PMID 23273589, PMID 23764181, PMID 24099865, PMID 24100924, PMID 24383844, PMID 24758527, PMID 24827132, PMID 25114718, PMID 25135992, PMID 25361995, PMID 25527568, PMID 25621498, PMID 26163096, PMID 26242208, PMID 28624696, PMID 28830573, PMID 29724294, PMID 29913374, PMID 30179569, PMID 30402678, PMID 30633128, PMID 31178155, PMID 33555272, PMID 38195521

NIH funding

P30CA068485 (6), U10CA032102 (5), P30CA036727 (3), P01HL036444 (2), U10CA031946 (2), K23HL084054 (1), P01CA018029 (1), P01CA078902 (1), P30CA006973 (1), P30CA012197 (1), P30CA015083 (1), P30CA022453 (1), P30CA033572 (1), P30CA043703 (1), P30CA082709 (1)